Ocuphire Posts Second Phase III Success In Reversing Pupil Dilation

 
• By Joseph Haas
Eye exam
Ocuphire hopes Nyxol will prove a popular option with eye exam patients • Source: Alamy

More from Clinical Trials

More from R&D